WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Gordon Scott has been an active investor and technical analyst or ...
IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results